Alzheimer's setback as promising drug shows no benefit in clinical trials - The Guardian

Submitted by Anonymous (not verified) on Tue, 01/09/2018 - 16:30

The GuardianAlzheimer's setback as promising drug shows no benefit in clinical trialsThe GuardianWriting in the Journal of the American Medical Association, an international team of researchers report how they carried out three clinical trials involving a total of 2,525 participants in 34 countries, to explore the impact of idalopirdine. All ...and more »